Maynard Um
-
-
-
-
-
-
-
Bernstein SocGen Group Starts BioNTech (BNTX) at Market Perform
-
-
-
-
-
-
-
BioNTech (BNTX) PT Lowered to $130 at H.C. Wainwright
-
-
-
-
-
-
-
Truist Securities Reiterates Buy Rating on BioNTech (BNTX) following earnings, management changes
-
-
-
-
-
-
-
BMO Capital on BioNTech (BNTX): 'Catalyst-Rich 2026 to Spotlight Differentiation of Onc Assets'
-
-
-
-
-
-
-
Shares of vaccine makers drop after FDA memo flags reports of child deaths
-
-
-
-
-
-
-
BioNTech Commences Public Exchange Offer for All Outstanding Shares of CureVac N.V.
-
-
-
-
-
-
-
CDC Panel Votes To End Universal Recommendation For Covid Shots - Bloomberg
-
439,172 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

